Clinical trial
Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute…
NCT00256100 · Melbourne Health, Other · Terminated
Key facts
| NCT number | NCT00256100 |
|---|---|
| Title | Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure. |
| Official title | Assessment of the Safety and Efficacy of Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Renal Failure. |
| Lead sponsor | Melbourne Health, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Renal Failure |
| Intervention type | Drug |
| Interventions | Fondaparinux Sodium |
| Enrollment | 20 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Nov 21, 2005 |
| Last update posted | Apr 12, 2017 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: